Back to Results
First PageMeta Content
Pharmacology / Health / Pharmaceuticals policy / Therapeutics / United States Public Health Service / New Drug Application / Ranbaxy Laboratories / Generic drug / Center for Drug Evaluation and Research / Food and Drug Administration / Pharmaceutical sciences / Pharmaceutical industry


FOOD AND DRUG LAW JOURNAL Enforcement Analyzing the Laws, Regulations, and Policies
Add to Reading List

Open Document

File Size: 429,96 KB

Share Result on Facebook

Company

Warns Disaster-Prone Company / CDER / Ranbaxy Laboratories Limited / /

Country

United States / India / /

Event

FDA Phase / /

Facility

Paonta Sahib Plant / Paonta Sahib facility / /

IndustryTerm

internal audit / approval applications / generic drug manufacturer / lesser-known tools / manufacturing controls documentation / drug approval applications / application or applications / abbreviated and new drug applications / manufacturing specifications / fraudulent applications / finished drug products / active pharmaceutical ingredients / manufacturing processes / premarket approval applications / /

Organization

Division of Manufacturing and Product Quality / CDER’s office of Compliance / office of Compliance / office of Regulatory Affairs / FDA / Center for Drug Evaluation and Research / Dewas / Paonta Sahib and Batamandi Unit / /

Person

Janet Woodcock / Jim Edwards / Compliance / Paula Katz / Deborah Autor / George Eliot / Malvinder Mohan Singh / /

/

Position

investigator / Director / CEO and Managing Director / consultant / major producer / Regulatory Counsel / /

Product

Paonta Sahib / /

Technology

more sophisticated tools / http / pdf / /

URL

http /

SocialTag